Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial

Neurotherapeutics · Published 2026-07-27 · DOI 10.1016/j.neurot.2026.e00953

Free full text

Authors (25)

Xiaolu Liu, Wencheng Fu, Xuanye Cui, Yi Feng, Bin Wen, Lei Shan, Xin Xu, Jian Yang, Jiquan Zhang, Lizhu He, Yingjun Zang, Shengchao Zhao, Xiaoli Yao, Yaling Liu, Mingming Ma, Baoxin Du, Jingxia Dang, Zhangyu Zou, Honglin Feng, Zuneng Lu, Yong Zhang, Zhiying Wu, Huifang Shang, Ping Yin, Dongsheng Fan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Liu, X., Fu, W., Cui, X., et al. (2026). Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e00953

Related articles